The DOI matches its Crossref record; 171 of the 171 references it cites were found in a registry or an index.
The Mitochondrial Chaperone TRAP1 Promotes Neoplastic Growth by Inhibiting Succinate Dehydrogenase
Open accessAbstract
Summary We report that the mitochondrial chaperone TRAP1, which is induced in most tumor types, is required for neoplastic growth and confers transforming potential to noncancerous cells. TRAP1 binds to and inhibits succinate dehydrogenase (SDH), the complex II of the respiratory chain. The respiratory downregulation elicited by TRAP1 interaction with SDH promotes tumorigenesis by priming the succinate-dependent stabilization of the proneoplastic transcription factor HIF1α independently of hypoxic conditions. These findings provide a mechanistic clue to explain the switch to aerobic glycolysis of tumors and identify TRAP1 as a promising antineoplastic target.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Sirtuin-3 deacetylation of cyclophilin D induces dissociation of hexokinase II from the mitochondria
Shulga, N., Wilson-Smith, R., & Pastorino, J. G. (2010) · Journal of Cell Science · doi:10.1242/jcs.061846 · Cited by 163
RetractedHallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425
Slamon, D. J., Clark, G. M., Wong, S. G., Levin, W. J., Ullrich, A., & McGuire, W. L. (1987) · Science · doi:10.1126/science.3798106 · Cited by 11,760
Mantovani, A., Allavena, P., Sica, A., & Balkwill, F. (2008) · Nature · doi:10.1038/nature07205 · Cited by 11,399
Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery
Datta, S. R., Dudek, H., Tao, X., Masters, S., Fu, H., Gotoh, Y., & Greenberg, M. E. (1997) · Cell · doi:10.1016/s0092-8674(00)80405-5 · Cited by 5,689
Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
Trachootham, D., Alexandre, J., & Huang, P. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2803 · Cited by 5,452
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218
Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients
Locatelli, F., Fishbane, S., Block, G. A., & Macdougall, I. C. (2017) · American Journal of Nephrology · doi:10.1159/000455166 · Cited by 4,813
Regulation of cancer cell metabolism
Cairns, R. A., Harris, I. S., & Mak, T. W. (2011) · Nature Reviews Cancer · doi:10.1038/nrc2981 · Cited by 4,744 · cited 1×
“To cope with the energetic requirements of rapid proliferation in these challenging conditions (Fritz and Fajas, 2010), tumor cells profoundly reorganize their core metabolism (Cairns et al., 2011; Levine and PuzioKuter, 2010).”
Background(1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-92-3-460_4 · Cited by 4,529
The metabolism of tumors in the body
Warburg, O., Wind, F., & Negelein, E. (1927) · Journal of General Physiology · doi:10.1085/jgp.8.6.519 · Cited by 4,416
Blume-Jensen, P., & Hunter, T. (2001) · Nature · doi:10.1038/35077225 · Cited by 3,738
ROS as signalling molecules: Mechanisms that generate specificity in ROS homeostasis
D'Autréaux, B., & Toledano, M. B. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2256 · Cited by 3,642
Dang, C. V. (2012) · Cell · doi:10.1016/j.cell.2012.03.003 · Cited by 3,390
MAP kinase signalling pathways in cancer
Dhillon, A. S., Hagan, S., Rath, O., & Kolch, W. (2007) · Oncogene · doi:10.1038/sj.onc.1210421 · Cited by 2,995
Mechanism of Activation of the RAF-ERK Signaling Pathway by Oncogenic Mutations of B-RAF
Wan, P. T. C., Garnett, M. J., Roe, S. M., Lee, S., Niculescu-Duvaz, D., Good, V. M., Project, C. G., Jones, C. M., Marshall, C. J., Springer, C. J., et al. (2004) · Cell · doi:10.1016/s0092-8674(04)00215-6 · Cited by 2,808
Apoptosis: controlled demolition at the cellular level
Taylor, R. C., Cullen, S. P., & Martin, S. J. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2312 · Cited by 2,624
DeBerardinis, R. J., Mancuso, A., Daikhin, E., Nissim, I., Yudkoff, M., Wehrli, S., & Thompson, C. B. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709747104 · Cited by 2,622
Hunter, T. (2000) · Cell · doi:10.1016/s0092-8674(00)81688-8 · Cited by 2,586
EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer
Singh, A., & Settleman, J. (2010) · Oncogene · doi:10.1038/onc.2010.215 · Cited by 2,545
HSP90 and the chaperoning of cancer
Whitesell, L., & Lindquist, S. L. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1716 · Cited by 2,502
Cancer cell metabolism: warburg and beyond
Hsu, P. P., & Sabatini, D. M. (2008) · Cell · doi:10.1016/j.cell.2008.08.021 · Cited by 2,452 · cited 2×
“Key to theWarburg effect is the decrease of mitochondrial respiration (Frezza and Gottlieb, 2009), which allows cancer cells to grow in the hypoxic conditions found in the interior of the tumor mass (Hsu and Sabatini, 2008).”
BackgroundVousden, K. H., & Lane, D. P. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2147 · Cited by 2,272
Gao, P., Tchernyshyov, I., Chang, T.-C., Lee, Y.-S., Kita, K., Ochi, T., Zeller, K. I., De Marzo, A. M., Van Eyk, J. E., Mendell, J. T., et al. (2009) · Nature · doi:10.1038/nature07823 · Cited by 2,124
Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-α prolyl hydroxylase
Selak, M. A., Armour, S. M., MacKenzie, E. D., Boulahbel, H., Watson, D. G., Mansfield, K. D., Pan, Y., Simon, M. C., Thompson, C. B., & Gottlieb, E. (2005) · Cancer Cell · doi:10.1016/j.ccr.2004.11.022 · Cited by 2,108
The Heat Shock Response: Life on the Verge of Death
Richter, K., Haslbeck, M., & Buchner, J. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.10.006 · Cited by 2,038
The essence of senescence: Figure 1.
Kuilman, T., Michaloglou, C., Mooi, W. J., & Peeper, D. S. (2010) · Genes & Development · doi:10.1101/gad.1971610 · Cited by 2,038
Ras, PI(3)K and mTOR signalling controls tumour cell growth
Shaw, R. J., & Cantley, L. C. (2006) · Nature · doi:10.1038/nature04869 · Cited by 2,019
HSP90 at the hub of protein homeostasis: emerging mechanistic insights
Taipale, M., Jarosz, D. F., & Lindquist, S. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2918 · Cited by 1,818
Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics
Semenza, G. L. (2010) · Oncogene · doi:10.1038/onc.2009.441 · Cited by 1,712
Hypoxia, HIF1 and glucose metabolism in the solid tumour
Denko, N. C. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2468 · Cited by 1,707
HIF1α and HIF2α: sibling rivalry in hypoxic tumour growth and progression
Keith, B., Johnson, R. S., & Simon, M. C. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3183 · Cited by 1,693
VEGF-targeted therapy: mechanisms of anti-tumour activity
Ellis, L. M., & Hicklin, D. J. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2403 · Cited by 1,673
Mutations in SDHD , a Mitochondrial Complex II Gene, in Hereditary Paraganglioma
Baysal, B. E., Ferrell, R. E., Willett-Brozick, J. E., Lawrence, E. C., Myssiorek, D., Bosch, A., Mey, A. V. D., Taschner, P. E. M., Rubinstein, W. S., Myers, E. N., et al. (2000) · Science · doi:10.1126/science.287.5454.848 · Cited by 1,638
The Multiple Leiomyoma Consortium (2002) · Nature Genetics · doi:10.1038/ng849 · Cited by 1,635
Hyperactive Ras in developmental disorders and cancer
Schubbert, S., Shannon, K., & Bollag, G. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2109 · Cited by 1,583
Signal transduction by the c-Jun N-terminal kinase (JNK) — from inflammation to development
Ip, Y. T., & Davis, R. J. (1998) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(98)80143-9 · Cited by 1,547
The JNK signal transduction pathway
Weston, C. (2002) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(01)00258-1 · Cited by 1,528
The glamour and gloom of glycogen synthase kinase-3
Jope, R. S., & Johnson, G. V. W. (2004) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2003.12.004 · Cited by 1,517
Targeting the dynamic HSP90 complex in cancer
Trepel, J., Mollapour, M., Giaccone, G., & Neckers, L. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2887 · Cited by 1,514
Ras oncogenes: split personalities
Karnoub, A. E., & Weinberg, R. A. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2438 · Cited by 1,467
Heat shock factors: integrators of cell stress, development and lifespan
Åkerfelt, M., Morimoto, R. I., & Sistonen, L. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2938 · Cited by 1,455
Chipuk, J. E., Moldoveanu, T., Llambi, F., Parsons, M. J., & Green, D. R. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.01.025 · Cited by 1,427
The multifaceted roles of glycogen synthase kinase 3β in cellular signaling
Grimes, C. A., & Jope, R. S. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(01)00011-9 · Cited by 1,423
HIF-1: upstream and downstream of cancer metabolism
Semenza, G. L. (2010) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2009.10.009 · Cited by 1,372
The Control of the Metabolic Switch in Cancers by Oncogenes and Tumor Suppressor Genes
Levine, A. J., & Puzio-Kuter, A. M. (2010) · Science · doi:10.1126/science.1193494 · Cited by 1,243
c-MYC: more than just a matter of life and death
Pelengaris, S., Khan, M., & Evan, G. (2002) · Nature Reviews Cancer · doi:10.1038/nrc904 · Cited by 1,178
Parallel progression of primary tumours and metastases
Klein, C. A. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2627 · Cited by 1,133
Targeting the mitogen-activated protein kinase cascade to treat cancer
Sebolt-Leopold, J. S., & Herrera, R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1503 · Cited by 1,108
Pathways of apoptotic and non-apoptotic death in tumour cells
Okada, H., & Mak, T. W. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1412 · Cited by 1,044
Role of Glycogen Synthase Kinase-3 in the Phosphatidylinositol 3-Kinase/Akt Cell Survival Pathway
Pap, M., & Cooper, G. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.32.19929 · Cited by 1,040
Vousden, K. H., & Ryan, K. M. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2715 · Cited by 959
Isaacs, J. S., Jung, Y. J., Mole, D. R., Lee, S., Torres-Cabala, C., Chung, Y.-L., Merino, M., Trepel, J., Zbar, B., Toro, J., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.06.017 · Cited by 958
Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis
Sparmann, A., & Bar-Sagi, D. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.09.028 · Cited by 851
Telomeres and telomerase: Their mechanisms of action and the effects of altering their functions
Blackburn, E. H. (2005) · FEBS Letters · doi:10.1016/j.febslet.2004.11.036 · Cited by 838
mtDNA mutations increase tumorigenicity in prostate cancer
Petros, J. A., Baumann, A. K., Ruiz-Pesini, E., Amin, M. B., Sun, C. Q., Hall, J., Lim, S., Issa, M. M., Flanders, W. D., Hosseini, S. H., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408894102 · Cited by 836
Diversity of degradation signals in the ubiquitin–proteasome system
Ravid, T., & Hochstrasser, M. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2468 · Cited by 826
Coller, H. A., Grandori, C., Tamayo, P., Colbert, T., Lander, E. S., Eisenman, R. N., & Golub, T. R. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.7.3260 · Cited by 823
Targeting Mitochondrial Glutaminase Activity Inhibits Oncogenic Transformation
Wang, J.-B., Erickson, J. W., Fuji, R., Ramachandran, S., Gao, P., Dinavahi, R., Wilson, K. F., Ambrosio, A. L. B., Dias, S. M. G., Dang, C. V., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.08.009 · Cited by 821
A Mutant-p53/Smad Complex Opposes p63 to Empower TGFβ-Induced Metastasis
Adorno, M., Cordenonsi, M., Montagner, M., Dupont, S., Wong, C., Hann, B., Solari, A., Bobisse, S., Rondina, M. B., Guzzardo, V., et al. (2009) · Cell · doi:10.1016/j.cell.2009.01.039 · Cited by 782
Ras proteins: different signals from different locations
Hancock, J. F. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1105 · Cited by 756
Targeting the tumour vasculature: insights from physiological angiogenesis
Chung, A. S., Lee, J., & Ferrara, N. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2868 · Cited by 752
The BRAF–MAPK signaling pathway is essential for cancer-immune evasion in human melanoma cells
Sumimoto, H., Imabayashi, F., Iwata, T., & Kawakami, Y. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20051848 · Cited by 698
PI3K/Akt: getting it right matters
Franke, T. F. (2008) · Oncogene · doi:10.1038/onc.2008.313 · Cited by 695
Targeting the cancer kinome through polypharmacology
Knight, Z. A., Lin, H., & Shokat, K. M. (2010) · Nature reviews. Cancer · doi:10.1038/nrc2787 · Cited by 674
Succinate dehydrogenase and fumarate hydratase: linking mitochondrial dysfunction and cancer
King, A., Selak, M. A., & Gottlieb, E. (2006) · Oncogene · doi:10.1038/sj.onc.1209594 · Cited by 672
Peptidyl-prolyl cis-trans isomerases, a superfamily of ubiquitous folding catalysts
G�thel, S. F., & Marahiel, M. A. (1999) · Cellular and Molecular Life Sciences (CMLS) · doi:10.1007/s000180050299 · Cited by 647
Mantovani, A. (2009) · Nature · doi:10.1038/457036b · Cited by 643
Integrating signals from RTKs to ERK/MAPK
McKay, M. M., & Morrison, D. K. (2007) · Oncogene · doi:10.1038/sj.onc.1210394 · Cited by 621
Erk Associates with and Primes GSK-3β for Its Inactivation Resulting in Upregulation of β-Catenin
Ding, Q., Xia, W., Liu, J.-C., Yang, J.-Y., Lee, D.-F., Xia, J., Bartholomeusz, G., Li, Y., Pan, Y., Li, Z., et al. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.06.009 · Cited by 597
PINK1 Protects against Oxidative Stress by Phosphorylating Mitochondrial Chaperone TRAP1
Pridgeon, J. W., Olzmann, J. A., Chin, L.-S., & Li, L. (2007) · PLoS Biology · doi:10.1371/journal.pbio.0050172 · Cited by 596
Protection by Cyclosporin A of Ischemia/Reperfusion-Induced Damage in Isolated Rat Hearts
Griffiths, E. J., & Halestrap, A. P. (1993) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1993.1162 · Cited by 585
Function and Structure of Complex II of the Respiratory Chain
Cecchini, G. (2003) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.72.121801.161700 · Cited by 556
Mitochondrial hexokinases, novel mediators of the antiapoptotic effects of growth factors and Akt
Robey, R. B., & Hay, N. (2006) · Oncogene · doi:10.1038/sj.onc.1209595 · Cited by 536
Reperfusion injury salvage kinase signalling: taking a RISK for cardioprotection
Hausenloy, D. J., & Yellon, D. M. (2007) · Heart Failure Reviews · doi:10.1007/s10741-007-9026-1 · Cited by 509
Rasola, A., & Bernardi, P. (2007) · Apoptosis · doi:10.1007/s10495-007-0723-y · Cited by 508
Self-citationHaem oxygenase is synthetically lethal with the tumour suppressor fumarate hydratase
Frezza, C., Zheng, L., Folger, O., Rajagopalan, K. N., MacKenzie, E. D., Jerby, L., Micaroni, M., Chaneton, B., Adam, J., Hedley, A., et al. (2011) · Nature · doi:10.1038/nature10363 · Cited by 503
Self-citationEferl, R., Ricci, R., Kenner, L., Zenz, R., David, J.-P., Rath, M., & Wagner, E. F. (2003) · Cell · doi:10.1016/s0092-8674(03)00042-4 · Cited by 474
Regulation of Tumor Cell Mitochondrial Homeostasis by an Organelle-Specific Hsp90 Chaperone Network
Kang, B. H., Plescia, J., Dohi, T., Rosa, J., Doxsey, S. J., & Altieri, D. C. (2007) · Cell · doi:10.1016/j.cell.2007.08.028 · Cited by 443
Bello, D. (1997) · Carcinogenesis · doi:10.1093/carcin/18.6.1215 · Cited by 438
Chaperones in control of protein disaggregation
Liberek, K., Lewandowska, A., & Ziętkiewicz, S. (2008) · The EMBO Journal · doi:10.1038/sj.emboj.7601970 · Cited by 425
Puisségur, M.-P., Mazure, N. M., Bertero, T., Pradelli, L., Grosso, S., Robbe-Sermesant, K., Maurin, T., Lebrigand, K., Cardinaud, B., Hofman, V, et al. (2011) · Cell Death & Differentiation · doi:10.1038/cdd.2010.119 · Cited by 423
The PTEN, Mdm2, p53 tumor suppressor–oncoprotein network
Mayo, L. D., & Donner, D. B. (2002) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(02)02166-7 · Cited by 410
Bardella, C., Pollard, P. J., & Tomlinson, I. (2011) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2011.07.003 · Cited by 395
The HSP90 family of genes in the human genome: Insights into their divergence and evolution
Chen, B., Piel, W. H., Gui, L., Bruford, E., & Monteiro, A. (2005) · Genomics · doi:10.1016/j.ygeno.2005.08.012 · Cited by 383
Clarke, S. J., McStay, G. P., & Halestrap, A. P. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202191200 · Cited by 376
The hsp90-related Protein TRAP1 Is a Mitochondrial Protein with Distinct Functional Properties
Felts, S. J., Owen, B. A. L., Nguyen, P., Trepel, J., Donner, D. B., & Toft, D. O. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.5.3305 · Cited by 370
Gimenez-Roqueplo, A.-P., Favier, J., Rustin, P., Mourad, J.-J., Plouin, P.-F., Corvol, P., Rötig, A., & Jeunemaitre, X. (2001) · The American Journal of Human Genetics · doi:10.1086/324413 · Cited by 364
MacKenzie, E. D., Selak, M. A., Tennant, D. A., Payne, L. J., Crosby, S., Frederiksen, C. M., Watson, D. G., & Gottlieb, E. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01927-06 · Cited by 359
Bcl-2 inhibitors: small molecules with a big impact on cancer therapy
Vogler, M., Dinsdale, D., Dyer, M. J. S., & Cohen, G. M. (2009) · Cell Death & Differentiation · doi:10.1038/cdd.2008.137 · Cited by 357
Miyamoto, S., Murphy, A. N., & Brown, J. H. (2008) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4402285 · Cited by 339
Gomez, L., Paillard, M., Thibault, H., Derumeaux, G., & Ovize, M. (2008) · Circulation · doi:10.1161/circulationaha.107.755066 · Cited by 335
Induction of a proinflammatory program in normal human thyrocytes by the RET/PTC1 oncogene
Borrello, M. G., Alberti, L., Fischer, A., Degl'Innocenti, D., Ferrario, C., Gariboldi, M., Marchesi, F., Allavena, P., Greco, A., Collini, P., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503039102 · Cited by 331
Lack of PTEN sequesters CHK1 and initiates genetic instability
Puc, J., Keniry, M., Li, H. S., Pandita, T. K., Choudhury, A. D., Memeo, L., Mansukhani, M., Murty, V. V. V. S., Gaciong, Z., Meek, S. E. M., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.01.009 · Cited by 328
Huang, L.-S., Sun, G., Cobessi, D., Wang, A. C., Shen, J. T., Tung, E. Y., Anderson, V. E., & Berry, E. A. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m511270200 · Cited by 308
Giorgio, V., Bisetto, E., Soriano, M. E., Dabbeni-Sala, F., Basso, E., Petronilli, V., Forte, M. A., Bernardi, P., & Lippe, G. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.020115 · Cited by 305
Self-citationTargeting mTOR: prospects for mTOR complex 2 inhibitors in cancer therapy
Sparks, C. A., & Guertin, D. A. (2010) · Oncogene · doi:10.1038/onc.2010.139 · Cited by 299
CROMPTON, M., & COSTI, A. (1988) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1988.tb14475.x · Cited by 297
Chiara, F., Castellaro, D., Marin, O., Petronilli, V., Brusilow, W. S., Juhaszova, M., Sollott, S. J., Forte, M., Bernardi, P., & Rasola, A. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001852 · Cited by 290
Self-citationMajewski, N., Nogueira, V., Robey, R. B., & Hay, N. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.2.730-740.2004 · Cited by 289
Klein, C. A. (2008) · Science · doi:10.1126/science.1164853 · Cited by 272
Mitochondria in cancer: Not just innocent bystanders
Frezza, C., & Gottlieb, E. (2009) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2008.11.008 · Cited by 268
Self-citationA novel CDK5‐dependent pathway for regulating GSK3 activity and kinesin‐driven motility in neurons
Morfini, G., Szebenyi, G., Brown, H., Pant, H. C., Pigino, G., DeBoer, S., Beffert, U., & Brady, S. T. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600237 · Cited by 268
Direct, activating interaction between glycogen synthase kinase-3β and p53 after DNA damage
Watcharasit, P., Bijur, G. N., Zmijewski, J. W., Song, L., Zmijewska, A., Chen, X., Johnson, G. V. W., & Jope, R. S. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.122062299 · Cited by 266
Cellular senescence in vivo: a barrier to tumorigenesis
Prieur, A., & Peeper, D. S. (2008) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2008.01.007 · Cited by 260
Ishii, T., Yasuda, K., Akatsuka, A., Hino, O., Hartman, P. S., & Ishii, N. (2005) · Cancer Research · doi:10.1158/0008-5472.203.65.1 · Cited by 253
Eickholt, B. J., Walsh, F. S., & Doherty, P. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200201098 · Cited by 243
Kang, B. H., Plescia, J., Song, H. Y., Meli, M., Colombo, G., Beebe, K., Scroggins, B., Neckers, L., & Altieri, D. C. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37613 · Cited by 240
Intramitochondrial signaling: interactions among mitoKATP, PKCε, ROS, and MPT
Costa, A. D. T., & Garlid, K. D. (2008) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01189.2007 · Cited by 238
Buday, L., & Downward, J. (2008) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2008.05.001 · Cited by 230
Hypoxia and energetic tumour metabolism
Brahimi-Horn, M. C., Bellot, G., & Pouysségur, J. (2011) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2010.10.006 · Cited by 226
Rasola, A., Sciacovelli, M., Chiara, F., Pantic, B., Brusilow, W. S., & Bernardi, P. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0912742107 · Cited by 225
Self-citationThe permeability transition pore complex in cancer cell death
Brenner, C., & Grimm, S. (2006) · Oncogene · doi:10.1038/sj.onc.1209609 · Cited by 220
Bhamra, G. S., Hausenloy, D. J., Davidson, S. M., Carr, R. D., Paiva, M., Wynne, A. M., Mocanu, M. M., & Yellon, D. M. (2008) · Basic Research in Cardiology · doi:10.1007/s00395-007-0691-y · Cited by 210
The Myc-dependent angiogenic switch in tumors is mediated by interleukin 1β
Shchors, K., Shchors, E., Rostker, F., Lawlor, E. R., Brown-Swigart, L., & Evan, G. I. (2006) · Genes & Development · doi:10.1101/gad.1455706 · Cited by 200
Heat Shock Protein 60 Regulation of the Mitochondrial Permeability Transition Pore in Tumor Cells
Ghosh, J. C., Siegelin, M. D., Dohi, T., & Altieri, D. C. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-2225 · Cited by 193
Metabolism and proliferation share common regulatory pathways in cancer cells
Fritz, V, & Fajas, L. (2010) · Oncogene · doi:10.1038/onc.2010.182 · Cited by 192
Rotem, R., Heyfets, A., Fingrut, O., Blickstein, D., Shaklai, M., & Flescher, E. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3091 · Cited by 191
Hua, G., Zhang, Q., & Fan, Z. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703196200 · Cited by 187
TRAP-1, the mitochondrial Hsp90
Altieri, D. C., Stein, G. S., Lian, J. B., & Languino, L. R. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2011.08.007 · Cited by 186
Features and applications of blue‐native and clear‐native electrophoresis
Wittig, I., & Schägger, H. (2008) · PROTEOMICS · doi:10.1002/pmic.200800017 · Cited by 184
Signal transduction to the permeability transition pore
Rasola, A., Sciacovelli, M., Pantic, B., & Bernardi, P. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.02.022 · Cited by 178
Self-citationArteel, G. E., Thurman, R. G., & Raleigh, J. A. (1998) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1998.2530743.x · Cited by 176
Gesualdi, N. M., Chirico, G., Pirozzi, G., Costantino, E., Landriscina, M., & Esposito, F. (2007) · Stress · doi:10.1080/10253890701314863 · Cited by 171
Self-citationThe carbohydrate metabolism of certain pathological overgrowths
Crabtree, H. G. (1928) · Biochemical Journal · doi:10.1042/bj0221289 · Cited by 168
Labi, V, Grespi, F., Baumgartner, F., & Villunger, A. (2008) · Cell Death & Differentiation · doi:10.1038/cdd.2008.37 · Cited by 165
The retinoblastoma tumor-suppressor gene, the exception that proves the rule
Goodrich, D. W. (2006) · Oncogene · doi:10.1038/sj.onc.1209616 · Cited by 164
Lü, G., Ren, S. V., Kôrge, P., Choi, J., Dong, Y., Weiss, J. N., Koehler, C. M., Chen, J., & Wang, Y. (2007) · Genes & Development · doi:10.1101/gad.1499107 · Cited by 160
Gasparre, G., Hervouet, É., de Laplanche, E., Demont, J., Pennisi, L. F., Colombel, M. C., Mège‐Lechevallier, F., Scoazec, J., Bonora, E., Smeets, R., et al. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm371 · Cited by 156
Suppression of Ras-stimulated transformation by the JNK signal transduction pathway
Kennedy, N. J., Sluss, H. K., Jones, S. N., Bar‐Sagi, D., Flavell, R. A., & Davis, R. J. (2003) · Genes & Development · doi:10.1101/gad.1062903 · Cited by 152
Involvement of the p38 mitogen‐activated protein kinase cascade in hepatocellular carcinoma
Iyoda, K., Sasaki, Y., Horimoto, M., Toyama, T., Yakushijin, T., Sakakibara, M., Takehara, T., Fujimoto, J., Hori, M., Wands, J. R., et al. (2003) · Cancer · doi:10.1002/cncr.11425 · Cited by 152
Cancer Metabolism: Is Glutamine Sweeter than Glucose?
Lu, W., Pelicano, H., & Huang, P. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.08.017 · Cited by 148
Baracca, A., Chiaradonna, F., Sgarbi, G., Solaini, G., Alberghina, L., & Lenaz, G. (2009) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2009.11.006 · Cited by 146
Machida, K., Ohta, Y., & Osada, H. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m513297200 · Cited by 144
Mitochondrial respiratory chain complexes: apoptosis sensors mutated in cancer?
Lemarié, A., & Grimm, S. (2011) · Oncogene · doi:10.1038/onc.2011.167 · Cited by 140
Costantino, E., Maddalena, F., Calise, S. J., Piscazzi, A., Tirino, V., Fersini, A., Ambrosi, A., Neri, V., Esposito, F., & Landriscina, M. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.01.018 · Cited by 140
Self-citationLeav, I., Plescia, J., Goel, H. L., Li, J., Jiang, Z., Cohen, R. J., Languino, L. R., & Altieri, D. C. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2010.090521 · Cited by 133
Immunophilins: Switched on protein binding domains?
Ivery, M. T. G. (2000) · Medicinal Research Reviews · Cited by 130
Beginnings of a signal-transduction pathway for bioenergetic control of cell survival
Hammerman, P. S., Fox, C. J., & Thompson, C. B. (2004) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2004.09.008 · Cited by 129
Reactivating HIF prolyl hydroxylases under hypoxia results in metabolic catastrophe and cell death
Tennant, D. A., Frezza, C., MacKenzie, E. D., Nguyen, Q., Zheng, L., Selak, M. A., Roberts, D. L., Dive, C., Watson, D. G., Aboagye, E. O., et al. (2009) · Oncogene · doi:10.1038/onc.2009.250 · Cited by 129
Self-citationCyclophilin D, a Component of the Permeability Transition-Pore, Is an Apoptosis Repressor
Schubert, A., & Grimm, S. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-0476 · Cited by 128
Rasola, A., Fassetta, M., Bacco, F. D., D'Alessandro, L., Gramaglia, D., Renzo, M. F. D., & Comoglio, P. M. (2006) · Oncogene · doi:10.1038/sj.onc.1209859 · Cited by 127
Self-citationApoptosis-inducing antitumor efficacy of hexokinase II inhibitor in hepatocellular carcinoma
Kim, W. K., Yoon, J., Jeong, J. M., Cheon, G. J., Lee, T. S., Yang, J. I., Park, S.-C., & Lee, H.-S. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0115 · Cited by 115
Li, P.-A., Uchino, H., Elmér, E., & Siesjö, B. K. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00005-x · Cited by 114
Intrathecal cyclosporin prolongs survival of late-stage ALS mice
Keep, M. F., Elmér, E., Fong, K. S. K., & Csiszár, K. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02012-1 · Cited by 114
Amoroso, M. R., Matassa, D. S., Laudiero, G., Egorova, A. V., Polishchuk, R., Maddalena, F., Piscazzi, A., Paladino, S., Sarnataro, D., Garbi, C., et al. (2011) · Cell Death and Differentiation · doi:10.1038/cdd.2011.128 · Cited by 97
Self-citationHarnessing the immune response to treat cancer
Steer, H. J., Lake, R., Nowak, A. K., & Robinson, B. W. S. (2010) · Oncogene · doi:10.1038/onc.2010.437 · Cited by 96
Verrier, F., Deniaud, A., Bras, M. L., Métivier, D., Kroemer, G., Mignotte, B., Jan, G., & Brenner, C. (2004) · Oncogene · doi:10.1038/sj.onc.1208001 · Cited by 93
Soriano, M. E., Nicolosi, L., & Bernardi, P. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405297200 · Cited by 77
Self-citationAbu‐Amero, K. K., Alzahrani, A. S., Zou, M., & Shi, Y. (2004) · Oncogene · doi:10.1038/sj.onc.1208292 · Cited by 72
Klöhn, P., Soriano, M. E., Irwin, W., Penzo, D., Scorrano, L., Bitsch, A., Neumann, H., & Bernardi, P. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1633614100 · Cited by 69
Self-citationMitochondrial permeability transition as a novel principle of hepatorenal toxicity in vivo
Haouzi, D., COHEN, I. R., Vieira, H. L. A., Poncet, D., Boya, P., Castedo, M., Vadrot, N., Belzacq, A.-S., Fau, D., Brenner, C., et al. (2002) · APOPTOSIS · doi:10.1023/a:1020026923038 · Cited by 61
Selak, M. A., Durán, R. V., & Gottlieb, E. (2006) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2006.05.015 · Cited by 59
Compartmentalized cancer drug discovery targeting mitochondrial Hsp90 chaperones
Kang, B. H., & Altieri, D. C. (2009) · Oncogene · doi:10.1038/onc.2009.227 · Cited by 59
A New Paradigm for MAPK: Structural Interactions of hERK1 with Mitochondria in HeLa Cells
Galli, S., Jahn, O., Hitt, R., Hesse, D., Opitz, L., Plessmann, U., Urlaub, H., Poderoso, J. J., Jares-Erijman, E. A., & Jovin, T. M. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007541 · Cited by 58
Kobayashi, H., Miura, T., Ishida, H., Miki, T., Tanno, M., Yano, T., Sato, T., Hotta, H., & Shimamoto, K. (2008) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2008.04925.x · Cited by 54
Molecular chaperones as regulators of cell death
Hishiya, A., & Takayama, S.-I. J. (2008) · Oncogene · doi:10.1038/onc.2008.314 · Cited by 53
The complex dance of the molecular chaperone Hsp90
Neckers, L., Mollapour, M., & Tsutsumi, S. (2009) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2009.01.006 · Cited by 44
Alternative fuel—another role for p53 in the regulation of metabolism
Vousden, K. H. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1002656107 · Cited by 40
Gramaglia, D., Gentile, A., Battaglia, M., Ranzato, L., Petronilli, V., Fassetta, M., Bernardi, P., & Rasola, A. (2004) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401326 · Cited by 38
Self-citationThe impact of redox and thiol status on the bone marrow: Pharmacological intervention strategies
Grek, C. L., Townsend, D. M., & Tew, K. D. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.09.008 · Cited by 37
Developmental Abnormalities and Cancer Predisposition in Neurofibromatosis Type 1
Larizza, L., Gervasini, C., Natacci, F., & Riva, P. (2009) · Current Molecular Medicine · doi:10.2174/156652409788488801 · Cited by 36
Choi, Y., Kim, Y. S., Choi, I. Y., Kim, S.-W., & Kim, W.-K. (2008) · Free Radical Research · doi:10.1080/10715760802146062 · Cited by 33
Chewing the Fat on Tumor Cell Metabolism
Yecies, J. L., & Manning, B. D. (2010) · Cell · doi:10.1016/j.cell.2009.12.037 · Cited by 32
Xie, Q. R., Wondergem, R., Shen, Y., Cavey, G. S., Ke, J., Thompson, R., Bradley, R., Daugherty-Holtrop, J., Xu, Y., Chen, E., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1015181108 · Cited by 29
Fassetta, M., D’Alessandro, L. A., Coltella, N., Renzo, M. F. D., & Rasola, A. (2006) · Cellular Signalling · doi:10.1016/j.cellsig.2006.03.005 · Cited by 27
Self-citationRole of Phosphatidylinositol 3-Kinase/AKT as a Survival Pathway against CYP2E1-Dependent Toxicity
Caro, A. A., & Cederbaum, A. I. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.102921 · Cited by 20
β-tting on p63 as a Metastatic Suppressor
Clohessy, J. G., & Pandolfi, P. P. (2009) · Cell · doi:10.1016/j.cell.2009.03.028 · Cited by 11
Cited by
Mitochondrial metabolism and cancer
Porporato, P. E., Filigheddu, N., Pedro, J. M. B.-S., Kroemer, G., & Galluzzi, L. (2018) · Cell Research · doi:10.1038/cr.2017.155 · Cited by 1,273
Metabolic control of cell death
Green, D. R., Galluzzi, L., & Kroemer, G. (2014) · Science · doi:10.1126/science.1250256 · Cited by 647
Glycolytic Reprogramming in Myofibroblast Differentiation and Lung Fibrosis
Xie, N., Tan, Z., Banerjee, S., Cui, H., Ge, J., Liu, R.-M., Bernard, K., Thannickal, V. J., & Liu, G. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201504-0780oc · Cited by 582
Bernardi, P., Rasola, A., Forte, M., & Lippe, G. (2015) · Physiological Reviews · doi:10.1152/physrev.00001.2015 · Cited by 577
Self-citationMitochondria as playmakers of apoptosis, autophagy and senescence
Abate, M., Festa, A., Falco, M., Lombardi, A., Luce, A., Grimaldi, A., Zappavigna, S., Sperlongano, P., Irace, C., Caraglia, M., et al. (2020) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2019.05.022 · Cited by 545
Metadata
- Authors
- Sciacovelli, M., Guzzo, G., Morello, V., Frezza, C., Zheng, L., Nannini, N., Calabrese, F., Laudiero, G., Esposito, F., Landriscina, M., Defilippi, P., Bernardi, P., & Rasola, A.
- Venue
- Cell Metabolism
- Publisher
- Elsevier BV
- Published
- 2013-06
- Volume
- 17
- Issue
- 6
- Pages
- 988-999
- ISSN
- 1550-4131 (ISSN-L)
- OpenAlex
- W2122127456
- Cited by
- 264
- References
- 171
- FWCI
- 6.42
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.